PAP
GILD icon

Persistent Asset Partners’s Gilead Sciences GILD Stock Holding History

Persistent Asset Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.5K Buy
+194
New +$25.6K 0.01% 584
2025
Q3 		– Sell
-6,919
Closed -$767K – 267
2025
Q2 		$767K Buy
+6,919
New +$736K 0.57% 52

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Persistent Asset Partners's GILD Position: Q2 2026 in Review

Persistent Asset Partners opened a new position in Gilead Sciences (GILD) in Q2 2026: 194 shares worth $24.5K. The stake represents 0.01% of the portfolio and ranks #584 among its holdings. This is a return to the name: Persistent Asset Partners previously reported a position in GILD as recently as Q2 2025.

Persistent Asset Partners first reported a position in GILD in Q2 2025 and has held it in 2 quarters since. The position peaked at $767K in Q2 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Persistent Asset Partners held 194 shares of Gilead Sciences worth $24.5K as of Q2 2026.
  • Gilead Sciences was a new Persistent Asset Partners position in Q2 2026.
  • Gilead Sciences made up 0.01% of Persistent Asset Partners's portfolio in Q2 2026, its #584 holding.
  • Persistent Asset Partners first reported a position in Gilead Sciences in Q2 2025 and has held it in 2 quarters since.
  • Persistent Asset Partners's Gilead Sciences position peaked at $767K in Q2 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.